RESUMO
OBJECTIVE: To compare the efficacy and safety of three polyspecific antivenoms for bites by pit vipers. DESIGN: Randomised double blind comparative trial of three antivenoms. SETTING: Shell, Pastaza, southeastern Ecuador. PARTICIPANTS: 210 patients with incoagulable blood were recruited from 221 consecutive patients admitted with snake bite between January 1997 and December 2001. INTERVENTION: One of three antivenoms manufactured in Brazil, Colombia, and Ecuador, chosen for their preclinical potency against Ecuadorian venoms. MAIN OUTCOME MEASURES: Permanent restoration of blood coagulability after 6 and 24 hours. RESULTS: The snakes responsible for the bites were identified in 187 cases: 109 patients (58%) were bitten by Bothrops atrox, 68 (36%) by B bilineatus, and 10 (5%) by B taeniatus, B brazili, or Lachesis muta. Eighty seven patients (41%) received Colombian antivenom, 82 (39%) received Brazilian antivenom, but only 41 (20%) received Ecuadorian antivenom because the supply was exhausted. Two patients died, and 10 developed local necrosis. All antivenoms achieved the primary end point of permanently restoring blood coagulability by 6 or 24 hours after the start of treatment in > 40% of patients. Colombian antivenom, however, was the most effective after initial doses of 20 ml (two vials), < 70 ml, and any initial dose at both 6 and 24 hours. An initial dose of 20 ml of Colombian antivenom permanently restored blood coagulability in 64% (46/72) of patients after 6 hours (P = 0.054 compared with the other two antivenoms) and an initial dose of < 70 ml was effective at 6 hours (65%, P = 0.045) and 24 hours (99%, P = 0.06). Early anaphylactoid reactions were common (53%, 73%, and 19%, respectively, for Brazilian, Colombian, and Ecuadorian antivenoms, P < 0.0001) but only three reactions were severe and none was fatal. CONCLUSIONS: All three antivenoms can be recommended for the treatment of snakebites in this region, though the reactogenicity of Brazilian and Colombian antivenoms is a cause for concern.
Assuntos
Antivenenos/uso terapêutico , Venenos de Crotalídeos , Crotalus , Mordeduras de Serpentes/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Antivenenos/efeitos adversos , Antivenenos/sangue , Brasil , Criança , Pré-Escolar , Colômbia , Método Duplo-Cego , Equador , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do TratamentoRESUMO
Se evaluó la importancia de los factores raciales en la epidemiología y las manifestaciones clínicas de la oncocercosis en la raza negra y la raza indígena Chachi, dos grupos étnicos diferentes del área hiperendémica del foco oncocercótico ecuatoriano. Los Chachi presentaron una significativa mayor densidad de microfilarias en la piel. De los negros, 72,2 por ciento presentaron lesiones oncocercóticas en la piel comparado con 56,4 por ciento en los Chachi. Se encontró mayor prevalencia de nódulos palpables en los Chachi (51,4 por ciento vs. 43,0 por ciento). La presencia de microfilarias en la cámara anterior del ojo fue más frecuente en los Chachi (51,9 por ciento vs. 34,2 por ciento), pero se evidenció una mayor prevalencia de corioretinitis y atrofia del nervio óptico en los negros (17,6 por ciento vs 11,2 por ciento y 8,5 por ciento vs. 0,5 por ciento, respectivamente)
Assuntos
Humanos , Masculino , Feminino , Oncocercose/epidemiologia , População Negra/estatística & dados numéricos , Distribuição por Idade , Grupos Raciais , Equador/epidemiologia , Doenças Endêmicas/estatística & dados numéricos , Indígenas Sul-Americanos/genética , Microfilárias/isolamento & purificação , Oncocercose/genética , Distribuição por SexoRESUMO
The prevalence of onchocerciasis infection was determined in communities on 7 rivers located in the northern area of the canton San Lorenzo, province of Esmeraldas. Diagnosis of the infection was obtained by skin biopsies and recombinant-antigen based-serology. No evidence of infection was detected in 9 communities studied along the Rio Mataje, which forms the frontier between Ecuador and Colombia, nor in 10 adjacent communities located on 5 interior rivers. Evidence for Onchocerca volvulus infection was found in 4 communities on the Rio Tululvi with the following prevalence: La Boca (3,5 per cent by biopsy and 3,9 per cent by serology), Guayabal (9,1 per cent by both biopsy and serology), La Ceiva (51,5 per cent by biopsy and 53 per cent by serology), and Salidero (4 per cent by biopsy and 7,7 per cent by serology). A few individuals in these communities were seropositive for O. volvulus in the absence of detectable dermal microfilariae: these might harbor very light or prepatent infections. No clinical disease attributable to onchocerciasis was found. The infected communities will be included in the ivermectin-based National Control Program for the disease, with no evidence of the infection having extended north of the Ecuadorian-Colombian border.